Pablo Bellot Selected Research

Pablo Bellot Research Topics

Disease

20	Fibrosis (Cirrhosis) 09/2020 - 03/2006
5	Inflammation (Inflammations) 01/2020 - 01/2015
5	Portal Hypertension 10/2019 - 01/2006
5	Ascites 10/2019 - 03/2008
4	Hepatic Encephalopathy 10/2019 - 05/2004
3	Peritonitis 10/2019 - 03/2008
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2020
2	Bacterial Infections (Bacterial Infection) 01/2018 - 01/2015
2	Liver Diseases (Liver Disease) 01/2015 - 05/2013
2	Brain Diseases (Brain Disorder) 05/2013 - 01/2007
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	End Stage Liver Disease 10/2019
1	Endotoxemia 10/2019
1	Neoplasms (Cancer) 10/2016
1	Renal Insufficiency (Renal Failure) 03/2015
1	Melanoma (Melanoma, Malignant) 01/2015
1	Esophageal and Gastric Varices (Esophageal Varices) 08/2011
1	Rupture 08/2011
1	Hemorrhage 08/2011
1	Infections 12/2010
1	Hyperemia 12/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 12/2010
1	Hepatocellular Carcinoma (Hepatoma) 01/2009
1	Hepatitis 01/2009
1	Necrosis 01/2008
1	Alcoholic Hepatitis 02/2007
1	Acute-On-Chronic Liver Failure 02/2007

Drug/Important Bio-Agent (IBA)

8	Bacterial DNAIBA 01/2019 - 01/2008
5	Norfloxacin FDA Link 01/2018 - 03/2008
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2010 - 03/2008
3	CytokinesIBA 11/2009 - 03/2008
2	EndotoxinsIBA 10/2008 - 01/2008
1	Insulin (Novolin)FDA Link 01/2021
1	beta Adrenergic ReceptorsIBA 09/2020
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2020
1	CatecholaminesIBA 09/2020
1	Bacterial AntigensIBA 01/2020
1	Butyric Acid (Butanoic Acid)IBA 10/2019
1	Butyrates (Butyrate)IBA 10/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Rifaximin (L 105)FDA Link 01/2018
1	Lactulose (Duphalac)FDA LinkGeneric 01/2017
1	Dihydrotachysterol (AT 10)IBA 10/2016
1	Propranolol (Inderal)FDA LinkGeneric 10/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Dipyrone (Metamizole)IBA 03/2015
1	Vasodilator Agents (Vasodilators)IBA 03/2015
1	ProstaglandinsIBA 03/2015
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2015
1	Interleukin-18 (Interleukin 18)IBA 01/2015
1	Proton Pump InhibitorsIBA 01/2015
1	InflammasomesIBA 01/2015
1	Contrast MediaIBA 08/2011
1	Heme Oxygenase (Decyclizing) (Heme Oxygenase)IBA 03/2011
1	QuinolonesIBA 12/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2010
1	Peptides (Polypeptides)IBA 05/2010
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 11/2009
1	Sorafenib (BAY 43-9006)FDA Link 01/2009
1	Indicators and Reagents (Reagents)IBA 12/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2008
1	Interleukin-6 (Interleukin 6)IBA 01/2008
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 03/2006
1	Malondialdehyde (Propanedial)IBA 03/2006
1	AntioxidantsIBA 03/2006
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2006
1	ReninIBA 01/2006
1	AldosteroneIBA 01/2006

Therapy/Procedure

4	Therapeutics 10/2016 - 03/2006
3	Surgical Portasystemic Shunt (Portosystemic Shunt) 10/2019 - 01/2007
3	Transjugular Intrahepatic Portasystemic Shunt 05/2013 - 01/2007
1	Liver Transplantation 01/2019
1	Oral Administration 01/2018
1	Endovascular Procedures 08/2011
1	Microbubbles 08/2011
1	Prostheses and Implants (Prosthesis) 01/2007
1	Surgical Splenorenal Shunt (Splenorenal Shunt) 05/2004